Publication date: 4 Jan 2022
Associated community Muscular Dystrophy, Duchenne and Becker Types
You and your loved one are not alone in managing Duchenne muscular dystrophy. The LELANTOS I study is testing an investigational drug in patients with Duchenne muscular dystrophy who are non-ambulatory. The study is evaluating whether the drug can maintain or improve muscle strength of upper extremities and stabilizing respiratory and heart functions in Duchenne patients.
Duchenne patients who fit the following criteria may be eligible to participate:
A Duchenne muscular dystrophy diagnosis
Aged 12 or older
Currently unable to walk without braces or assistive devices
On a stable dose of corticosteroids for at least 6 months
Duchenne research can only move forward with volunteers. Answer a few questions to see if you or your loved one is eligible to take part in this clinical study:
Thank you for your interest!